What Are the Different Subtypes of POTS? (Key Symptoms)
At a Glance
Postural Orthostatic Tachycardia Syndrome (POTS) has three primary subtypes: neuropathic, hyperadrenergic, and hypovolemic. Many patients experience a combination of these underlying causes. Identifying your specific subtype through testing is essential for creating an effective treatment plan.
In this answer
3 sections
Postural Orthostatic Tachycardia Syndrome (POTS) is not a single, uniform condition, but rather a “heterogeneous” disorder. This means that while all patients with POTS experience an excessive heart rate increase upon standing, the underlying causes in their bodies can be very different [1][2]. To better understand these differences, doctors categorize POTS into three primary subtypes: neuropathic, hyperadrenergic, and hypovolemic [3]. Knowing which subtype—or combination of subtypes—you have is important because it directly guides which medications and lifestyle changes will be most effective for you [4][5].
The Three Primary Subtypes
1. Neuropathic POTS
In neuropathic POTS, the small nerve fibers that control your blood vessels do not function correctly [6]. Normally, when you stand up, your nervous system tells the blood vessels in your legs and abdomen to tighten (constrict) so blood doesn’t pool in your lower body. In neuropathic POTS, this tightening is impaired, leading to blood pooling [6]. To compensate for the lack of blood returning to the brain, your heart beats much faster [7].
- Key signs: Patients often notice changes in the color of their lower legs or feet when standing, such as turning red, purple (acrocyanosis), or mottled [8].
- Treatment focus: Treatment for this subtype often involves vasoconstrictors—medications that force the blood vessels to tighten—along with physical counter-maneuvers (like tightly crossing your legs or clenching your thigh muscles) to manually push blood upward [7]. Doctors also recommend medical-grade compression garments; waist-high or thigh-high compression is generally needed, as calf-high socks often aren’t enough to prevent blood from pooling in the thighs and abdomen [7].
2. Hyperadrenergic POTS
Hyperadrenergic refers to an overactive sympathetic nervous system—your body’s “fight or flight” response [1]. When a person with hyperadrenergic POTS stands up, their body releases excessively high levels of the stress hormone norepinephrine [1]. This surge not only causes a rapid heart rate but can also cause blood pressure to rise when standing [9].
- Key signs: You may feel severe anxiety, tremors, sweating, or palpitations upon standing [10].
- Treatment focus: This subtype is typically managed with medications like beta-blockers or ivabradine, which lower the heart rate and block adrenaline receptors [1][11]. Importantly, patients with this subtype must usually avoid medications known as norepinephrine-reuptake inhibitors (SNRIs, common in certain antidepressants or ADHD medications) [1]. These drugs prevent the body from clearing out excess stress hormones, which can worsen the hyperadrenergic state [1].
3. Hypovolemic POTS
Hypovolemic means having an unusually low overall volume of blood circulating in your body [12]. Because there is less blood to go around, your heart has to pump faster to ensure enough oxygen reaches your brain when you stand up against gravity [1].
- Key signs: Worsening symptoms when dehydrated, especially in the heat or first thing in the morning [1].
- Treatment focus: Management heavily relies on aggressive “volume expansion” [1]. This means increasing your daily intake of fluids (often 2 to 3 liters daily) and salt (several grams daily, as directed by your doctor) to help your body retain water and build up blood volume [12]. Exercise training is also heavily emphasized to improve cardiovascular conditioning [1]. If lifestyle modifications are not enough, doctors may prescribe volume-expanding medications like fludrocortisone or desmopressin [7].
Mixed Subtypes Are the Norm, Not the Exception
If you feel like your symptoms fit more than one of these categories, you are not alone. It is extremely common for patients to have a mix of these subtypes rather than fitting perfectly into just one [1][13]. For example, low blood volume (hypovolemia) might trigger your nervous system to overreact (hyperadrenergic) [7]. Because of this overlap, treatments often need to be mixed and matched.
How Does My Doctor Figure Out My Subtype?
Because treatments differ so much between subtypes, comprehensive testing is important [5]. While a standard head-up tilt-table test or active stand test confirms the baseline POTS diagnosis [7], finding your specific subtype may involve:
- Catecholamine testing: Drawing your blood to measure norepinephrine levels while you are lying down and again after you have been standing for a few minutes [1]. Levels over 600 pg/mL upon standing often point to hyperadrenergic POTS [1]. Note: You may be asked to pause certain medications before this test so they don’t interfere with the results.
- Autonomic testing: Specialized tests like sweat tests (sudomotor testing) or breathing tests to check the function of your small nerve fibers [14].
- Skin biopsies: A small sample of skin may be taken to look for small fiber nerve damage [15].
- Blood pressure monitoring: Watching if your blood pressure drops, stays the same, or spikes when you stand [16].
Understanding your subtype is an important step in taking control of your condition. By tailoring your treatment—whether it’s managing salt intake, wearing compression, or finding the right medication—you and your doctor can work toward a plan that addresses the root causes of your symptoms [5].
Common questions in this guide
What are the three main subtypes of POTS?
Why do my legs turn red or purple when I stand up?
How will my doctor figure out which POTS subtype I have?
Are there medications I should avoid if I have hyperadrenergic POTS?
How does treatment change depending on my POTS subtype?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my symptom history and past tests, which POTS subtype or combination of subtypes do you suspect I have?
- 2.Do we need to order standing catecholamine blood tests, skin biopsies, or specific autonomic tests to pinpoint my subtype?
- 3.How should my suspected subtype change my daily sodium and fluid intake goals?
- 4.Are any of my current medications, such as asthma inhalers, ADHD medications, or antidepressants, potentially worsening my symptoms if I have hyperadrenergic features?
- 5.What specific type of physical counter-maneuvers, compression garments, and exercise protocols are best suited for my subtype?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies.
Mar PL, Raj SR
Annual review of medicine 2020; (71()):235-248 doi:10.1146/annurev-med-041818-011630.
PMID: 31412221 - 2
Postural Orthostatic Tachycardia Syndrome (POTS)--A novel member of the autoimmune family.
Dahan S, Tomljenovic L, Shoenfeld Y
Lupus 2016; (25(4)):339-42 doi:10.1177/0961203316629558.
PMID: 26846691 - 3
Pathophysiological mechanisms of Postural Orthostatic Tachycardia Syndrome analyzed by means of hemodynamics.
Wei L, Cheng H, Chen S, et al.
PloS one 2025; (20(7)):e0327236 doi:10.1371/journal.pone.0327236.
PMID: 40601666 - 4
Maximizing treatment response in patients with neuropathic-subtype postural orthostatic tachycardia syndrome.
Rilinger RG, Chin AY, Cantrell C, et al.
Frontiers in neurology 2026; (17()):1796563 doi:10.3389/fneur.2026.1796563.
PMID: 42273028 - 5
Pediatric postural orthostatic tachycardia syndrome: From mechanisms to individualized management.
Xu W, Jin H, Liao Y, Du J
Pediatric discovery.. 2024; (2(4)):e2509 doi:10.1002/pdi3.2509.
PMID: 40626134 - 6
Skin Biopsy and Quantitative Sudomotor Axon Reflex Testing in Patients With Postural Orthostatic Tachycardia Syndrome.
Zhang R, Mayuga K, Shields R, et al.
Cureus 2022; (14(11)):e31021 doi:10.7759/cureus.31021.
PMID: 36349067 - 7
Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management.
Fedorowski A
Journal of internal medicine 2019; (285(4)):352-366 doi:10.1111/joim.12852.
PMID: 30372565 - 8
Bier anemic spots, cyanosis, and urticaria-like eruption (BASCULE) syndrome: Report of two new cases and literature review.
El Nemnom P, Lauwerys B, Marot L, et al.
Pediatric dermatology 2020; (37(5)):864-867 doi:10.1111/pde.14213.
PMID: 32648305 - 9
Identification and treatment of midaortic syndrome in an adult patient with orthostatic tachycardia and hypertension: A case report.
Pettinato AM, Kumar M, Kim AS
Heliyon 2024; (10(11)):e32186 doi:10.1016/j.heliyon.2024.e32186.
PMID: 38867988 - 10
Carbidopa: beyond Parkinson's disease.
Lenka A, Vernino S
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2025; (35(3)):347-352 doi:10.1007/s10286-025-01122-y.
PMID: 40056295 - 11
Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome.
Taub PR, Zadourian A, Lo HC, et al.
Journal of the American College of Cardiology 2021; (77(7)):861-871 doi:10.1016/j.jacc.2020.12.029.
PMID: 33602468 - 12
Recent advances in the understanding of the mechanisms underlying postural tachycardia syndrome in children: practical implications for treatment.
Zheng X, Chen Y, Du J
Cardiology in the young 2017; (27(3)):413-417 doi:10.1017/S1047951116002559.
PMID: 27938459 - 13
Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment.
Ruzieh M, Grubb BP
Herzschrittmachertherapie & Elektrophysiologie 2018; (29(2)):183-186 doi:10.1007/s00399-018-0563-1.
PMID: 29696346 - 14
A case series of cutaneous phosphorylated α-synuclein in Long-COVID POTS.
Miglis MG, Seliger J, Shaik R, Gibbons CH
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2022; (32(3)):209-212 doi:10.1007/s10286-022-00867-0.
PMID: 35570247 - 15
Cutaneous alpha-synuclein deposition in postural tachycardia patients.
Levine TD, Bellaire B, Gibbons C, Freeman R
Annals of clinical and translational neurology 2021; (8(4)):908-917 doi:10.1002/acn3.51347.
PMID: 33764697 - 16
Water Ingestion in Postural Orthostatic Tachycardia Syndrome: A Feasible Treatment Option?
The Journal of innovations in cardiac rhythm management 2019; (10(2)):3545-3551 doi:10.19102/icrm.2019.100207.
PMID: 32494413
This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider to discuss proper diagnostic testing and treatment for your specific POTS symptoms.
Get notified when new evidence is published on Postural Orthostatic Tachycardia Syndrome (POTS).
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.